Low-dose computed tomography scan and biopsy for assessing lung cancer prevalence and related factors in high-risk populations.

Background: Lung cancer is the second most diagnosed cancer and the leading cause of cancer death in 2020, representing approximately one in 10 (11.4 %) cancers diagnosed and one in 5 (18.0 %) deaths.